Primary Care Clinics in Old Town, ME Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Riversedge Chiropractic Wellness Center Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 227 Main St, Old Town, ME 04468 Phone: 207-827-5951 Fax: 720-368-0639 |
Pchc Walk In - Old Town Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128 |
Penobscot Community Health Center General Practice Medicare: Not Enrolled in Medicare Practice Location: 576 Stillwater Ave, Old Town, ME 04468 Phone: 207-404-8000 |
Penobscot Community Health Center General Practice Medicare: Not Enrolled in Medicare Practice Location: 203 Stillwater Ave, Old Town, ME 04468 Phone: 207-404-8000 |
Helen Hunt Health Center Family Medicine Medicare: Medicare Enrolled Practice Location: 242 Brunswick St, Old Town, ME 04468 Phone: 207-827-6128 Fax: 207-827-5533 |
Penobscot Community Health Center General Practice Medicare: Not Enrolled in Medicare Practice Location: 156 Oak St, Old Town, ME 04468 Phone: 207-404-8000 |
News Archive
New multidisciplinary task force to help clients identify, evaluate opportunities created by health care reform
Drawing on its analysis of the historic Patient Protection and Affordable Care Act of 2010, Squire, Sanders & Dempsey L.L.P. has established a multidisciplinary task force to help clients identify and evaluate key opportunities created by health care reform.
New research design offers way to assess safety of approved drugs
As the pace of drug approvals accelerates and the U.S. Food and Drug Administration faces potential budget cuts, a new research design from Perelman School of Medicine scientists offers a new way to successfully assess safety of newly approved drugs, as well as drugs that have been on the market for a long time and have had a marked rise in their use.
Humana reports first-quarter EPS of $1.52
Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended March 31, 2010 (1Q10) of $1.52, ahead of management's guidance of $1.10 to $1.20. EPS for 1Q10 included earnings of approximately $0.37 per share from higher-than-anticipated favorable prior-period development of medical claims reserves as well as $0.04 per share in higher-than-projected income tax expense due to recently enacted health reform legislation. Excluding these items, 1Q10 EPS was at the top end of the company's previous guidance range.
Findings explain molecular mechanisms underlying microvascular disease in diabetes patients
Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.
Study analyzes outcomes of brain metastases patients following stereotactic radiosurgery
Winner of the Leksell Radiosurgery Award, Deborah C. Marshall, recently presented her research, Survival Patterns of Patients with Cerebral Metastases after Multiple Rounds of Stereotactic Radiosurgery (SRS), at the 2015 American Association of Neurological Surgeons Annual Scientific Meeting.
› Verified 5 days ago